Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Scopus BioPharma Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 15 | 14 | −1 |
| Shares | 149.9K | 275.0K | +125.1K (+83.4%) |
| Value | $1.07M | $1.14M | +$70.0K (+6.5%) |
New holders (6)
Institutions that held Scopus BioPharma Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 101,654 | $422.0K | 0.00% |
| State Street Corp | 19,900 | $83.0K | 0.00% |
| Compagnie Lombard Odier SCmA | 4,360 | $18.0K | 0.00% |
| Harbour Investments, Inc. | 1,475 | $6.00K | 0.00% |
| Wells Fargo & Company | 49 | $0 | 0.00% |
| FMR LLC | 100 | $0 | 0.00% |
Sold out (7)
Institutions that held Scopus BioPharma Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Two Sigma Investments, LP | 31,416 | $224.0K |
| Ergoteles LLC | 23,450 | $167.0K |
| ExodusPoint Capital Management, LP | 16,069 | $115.0K |
| Captrust Financial Advisors | 95 | $1.00K |
| Bank of America Corp | 1 | $0 |
| New York State Common Retirement Fund | 43 | $0 |
| Citigroup Inc | 1 | $0 |